Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,780 | 32 | 43.4% |
| Food and Beverage | $4,740 | 305 | 43.0% |
| Consulting Fee | $1,500 | 1 | 13.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $4,821 | 25 | $0 (2023) |
| ABBVIE INC. | $2,057 | 21 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,350 | 105 | $0 (2024) |
| PFIZER INC. | $484.81 | 47 | $0 (2020) |
| MAYNE PHARMA INC. | $412.61 | 36 | $0 (2022) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $186.14 | 13 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $161.67 | 10 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $149.58 | 8 | $0 (2018) |
| Incyte Corporation | $141.76 | 7 | $0 (2024) |
| EPI Health, LLC | $135.00 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,342 | 20 | ABBVIE INC. ($1,213) |
| 2023 | $1,277 | 18 | ABBVIE INC. ($843.78) |
| 2022 | $1,576 | 31 | Allergan, Inc. ($1,167) |
| 2021 | $1,552 | 10 | Allergan, Inc. ($1,523) |
| 2020 | $110.09 | 7 | PFIZER INC. ($30.79) |
| 2019 | $868.01 | 73 | Galderma Laboratories, L.P. ($212.78) |
| 2018 | $1,331 | 84 | Galderma Laboratories, L.P. ($483.63) |
| 2017 | $2,963 | 95 | Allergan Inc. ($1,717) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $276.60 | General |
| 11/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.07 | General |
| 10/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $72.60 | General |
| 09/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $27.43 | General |
| 09/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Inflammation | ||||||
| 08/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $127.50 | General |
| 08/01/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.01 | General |
| 07/02/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $297.50 | General |
| 06/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $52.20 | General |
| 05/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Inflammation | ||||||
| 05/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $96.70 | General |
| 05/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: Dermatology | ||||||
| 05/01/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Dermatology | ||||||
| 04/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $26.91 | General |
| 04/11/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $26.20 | General |
| 03/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $24.20 | General |
| 01/05/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $95.10 | General |
| 11/28/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Inflammation | ||||||
| 11/09/2023 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $254.50 | General |
| 11/06/2023 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $12.98 | General |
| 10/23/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Podiatry | ||||||
| 10/06/2023 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $83.80 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,060 | 2,416 | $175,139 | $75,051 |
| 2022 | 11 | 1,001 | 2,474 | $166,552 | $71,028 |
| 2021 | 11 | 1,044 | 2,810 | $211,076 | $84,180 |
| 2020 | 12 | 1,005 | 2,252 | $214,690 | $71,064 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 263 | 367 | $51,120 | $22,683 | 44.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 154 | 187 | $29,492 | $12,651 | 42.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 199 | 304 | $31,707 | $11,792 | 37.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 151 | 1,234 | $12,756 | $6,171 | 48.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 34 | 40 | $10,515 | $4,262 | 40.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $10,059 | $4,182 | 41.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 28 | 40 | $7,070 | $3,321 | 47.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 79 | $6,895 | $2,937 | 42.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 21 | 21 | $4,116 | $1,885 | 45.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 14 | $3,779 | $1,870 | 49.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 43 | $3,364 | $1,721 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $2,364 | $991.01 | 41.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 17 | 17 | $1,903 | $585.10 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 242 | 336 | $47,584 | $20,179 | 42.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 150 | 183 | $29,748 | $13,549 | 45.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 195 | 279 | $29,552 | $10,510 | 35.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 162 | 1,408 | $15,066 | $7,443 | 49.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 40 | 50 | $13,325 | $6,813 | 51.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 64 | 64 | $11,140 | $4,155 | 37.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 29 | 29 | $5,857 | $2,218 | 37.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 46 | 47 | $4,151 | $1,765 | 42.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 37 | 42 | $3,402 | $1,744 | 51.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 23 | 23 | $4,130 | $1,602 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $2,597 | $1,050 | 40.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 263 | 409 | $51,660 | $26,746 | 51.8% |
About Dr. Stephen Laborde, MD
Dr. Stephen Laborde, MD is a Dermatology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962488106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Laborde, MD has received a total of $11,020 in payments from pharmaceutical and medical device companies, with $1,342 received in 2024. These payments were reported across 338 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,780).
As a Medicare-enrolled provider, Laborde has provided services to 4,110 Medicare beneficiaries, totaling 9,952 services with total Medicare billing of $301,323. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Houston, TX
- Active Since 12/20/2005
- Last Updated 06/22/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1962488106
Products in Payments
- RHOFADE (Drug) $1,655
- EUCRISA (Drug) $484.81
- EPIDUO FORTE (Drug) $472.24
- DORYX (Drug) $396.78
- SOOLANTRA (Drug) $183.66
- ORACEA (Drug) $154.13
- Finacea (Drug) $149.58
- OPZELURA (Drug) $141.76
- BOTOX (Biological) $123.27
- ONEXTON (Drug) $104.49
- SITAVIG (Drug) $104.12
- Otezla (Drug) $93.04
- KYBELLA (Biological) $81.17
- AKLIEF (Drug) $69.48
- ENSTILAR (Drug) $66.80
- Acticlate (Drug) $66.42
- SOLODYN (Drug) $61.39
- Sitavig (Drug) $61.10
- Ecoza (Drug) $54.19
- Impoyz (Drug) $52.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Houston
Dr. Alpesh Desai
Dermatology — Payments: $1.4M
Dr. Michael Migden, Md, MD
Dermatology — Payments: $379,143
Dr. Geeta Patel, D.o, D.O
Dermatology — Payments: $341,210
Catherine Papasakelariou, M.d, M.D
Dermatology — Payments: $270,262
Megan Couvillion, Md, MD
Dermatology — Payments: $154,211
Suzanne Bruce, M.d, M.D
Dermatology — Payments: $135,195